Stereotaxis (STXS) Cash & Current Investments (2010 - 2026)
Stereotaxis' (STXS) quarterly Cash & Current Investments came in at $14.6 million in Q1 2026, up 36.74% year-on-year from $10.7 million in Q1 2025, and up 8.9% on a QoQ basis from $13.4 million in Q4 2025.
Stereotaxis (STXS) Cash & Current Investments (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Cash & Current Investments data on file, last reported at $14.6 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 36.74% year-over-year to $14.6 million in Q1 2026; TTM through Mar 2026 was $14.6 million, a 36.74% increase from a year earlier, with the FY2025 full-year figure at $13.4 million, up 7.92% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $14.6 million, up from $13.4 million in the prior quarter.
- Over the last five years, Cash & Current Investments for STXS reached as high as $49.5 million in Q4 2022 and fell as low as $7.0 million in Q2 2025.
- Historically, Cash & Current Investments has averaged $20.3 million across 5 years, with a median of $15.6 million in 2024.
- Across the five-year window, Cash & Current Investments plunged 80.56% in 2023 and soared 157.67% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $49.5 million in 2022, then tumbled by 57.44% to $21.1 million in 2023, then tumbled by 41.03% to $12.4 million in 2024, then increased by 7.92% to $13.4 million in 2025, then advanced by 8.9% to $14.6 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $14.6 million in Q1 2026, $13.4 million in Q4 2025, and $10.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 816.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 1.66 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 561.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Stereotaxis | 128.56 Mn | 113.94 Mn | 3.79 Mn | 14.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.62 Mn |
| Dec 31, 2025 | 13.42 Mn |
| Sep 30, 2025 | 10.51 Mn |
| Jun 30, 2025 | 6.97 Mn |
| Mar 31, 2025 | 10.69 Mn |
| Dec 31, 2024 | 12.44 Mn |
| Sep 30, 2024 | 11.01 Mn |
| Jun 30, 2024 | 15.65 Mn |
| Mar 31, 2024 | 18.77 Mn |
| Dec 31, 2023 | 21.09 Mn |
| Sep 30, 2023 | 22.63 Mn |
| Jun 30, 2023 | 24.50 Mn |
| Mar 31, 2023 | 7.29 Mn |
| Dec 31, 2022 | 49.54 Mn |
| Sep 30, 2022 | 33.05 Mn |
| Jun 30, 2022 | 35.74 Mn |
| Mar 31, 2022 | 37.47 Mn |
| Dec 31, 2021 | 40.60 Mn |
| Sep 30, 2021 | 41.85 Mn |
| Jun 30, 2021 | 43.54 Mn |